Skip to main content
Log in

Mapping the functions of IgM antibodies in atherosclerotic cardiovascular disease

  • Comment
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

IgM antibodies have gained much attention as risk markers of atherosclerotic cardiovascular disease, but the exact antigenic determinants and the full spectrum of functions remain to be defined. A better understanding of the potentially diverse nature of the antigens that they recognize will help to dissect the function of IgM in atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Natural IgM in atherosclerosis.

References

  1. Mallat, Z. & Binder, C. J. The why and how of adaptive immune responses in ischemic cardiovascular disease. Nat. Cardiovasc. Res. 1, 431–444 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Porsch, F., Mallat, Z. & Binder, C. J. Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies. Cardiovasc. Res. 117, 2544–2562 (2021).

    CAS  PubMed  Google Scholar 

  3. Ylä-Herttuala, S. et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14, 32–40 (1994).

    Article  PubMed  Google Scholar 

  4. Baumgarth, N. B-1 cell heterogeneity and the regulation of natural and antigen-induced IgM production. Front. Immunol. 7, 324 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Blandino, R. & Baumgarth, N. Secreted IgM: New tricks for an old molecule. J. Leukoc. Biol. 106, 1021–1034 (2019).

    Article  CAS  PubMed  Google Scholar 

  6. Ehrenstein, M. R. & Notley, C. A. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10, 778–786 (2010).

    Article  CAS  PubMed  Google Scholar 

  7. Chou, M. Y. et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Invest. 119, 1335–1349 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Binder, C. J., Papac-Milicevic, N. & Witztum, J. L. Innate sensing of oxidation-specific epitopes in health and disease. Nat. Rev. Immunol. 16, 485–497 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Srikakulapu, P. et al. Perivascular adipose tissue harbors atheroprotective IgM-producing B cells. Front. Physiol. 8, 719 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Srikakulapu, P. et al. B-1b cells have unique functional traits compared to B-1a cells at homeostasis and in aged hyperlipidemic mice with atherosclerosis. Front. Immunol. 13, 909475 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

C.J.B. was supported by grants from the Austrian Science Fund (FWF SFB F54), the Leducq Foundation (TNE-20CVD03) and the Vienna Science and Technology Fund (LS18-090). The authors thank Dimitrios Tsiantoulas and Florentina Porsch (both at the Medical University of Vienna, Austria) for providing critical comments.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Christoph J. Binder.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deroissart, J., Binder, C.J. Mapping the functions of IgM antibodies in atherosclerotic cardiovascular disease. Nat Rev Cardiol 20, 433–434 (2023). https://doi.org/10.1038/s41569-023-00888-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-023-00888-w

  • Springer Nature Limited

Navigation